Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
100 participants
INTERVENTIONAL
2013-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Trial with medicinal product
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root
NCT02216851
Evaluation of a Novel Nasal Conformer in Pediatric Patients
NCT06885801
A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellansé-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds
NCT06243315
Evaluation of Nasal Elevator Versus Grayson's Nasal Stent with D-NAM Appliance on Nasolabial Esthetics in Bilateral Cleft Lip and Palate Infants
NCT06589453
A Prospective Study of the NUVANCE Facial Rejuvenation System for Mid-Face, Neck and Jowl Rejuvenation Procedures
NCT01100190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgery plus device (Nasella)
Person in need of surgery has cast for one week, then use of customized nasal brace for nose (Nasella) deformities during 8 weeks.
Use of customized nasal brace (Nasella) for nose deformities
corrective surgery
Surgery, no device thereafter
Person in need of surgery has cast for 1 week; thereafter no use of customized nasal brace (Nasella) .
corrective surgery
Only device (Nasella)
No need for surgery; use of customized nasal brace (Nasella) for nose deformities is made to improve look (cosmetic reason).
Use of customized nasal brace (Nasella) for nose deformities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of customized nasal brace (Nasella) for nose deformities
corrective surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Allergies to components of the nasal brace
* Diseases of the bone metabolism
* Medication affecting bone metabolism
* Drugs or alcohol abuse
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas N Roth, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Department of Otorhinolaryngology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Department of Otorhinolaryngology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Thomas Roth, Dr. med.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-0021
Identifier Type: OTHER
Identifier Source: secondary_id
RT_12_05_2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.